Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.46 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15187346 | 0.90 | L3MBTL1 (0.46) | L3MBTL1KMT2APOLBCYP1A2GAA | |
| SCHEMBL15187323 | 0.90 | L3MBTL1 (0.46) | L3MBTL1KMT2APOLBCYP1A2GAA | |
| SCHEMBL15187353 | 0.87 | CYP3A4 (0.53) | L3MBTL1KMT2APOLBCYP1A2ALDH1A1 | |
| SCHEMBL7291814 | 0.84 | L3MBTL1 (0.52) | L3MBTL1KMT2APOLBCYP1A2GAA | |
| SCHEMBL15183788 | 0.84 | L3MBTL1 (0.41) | L3MBTL1KMT2APOLBCYP1A2GAA | |
| SCHEMBL15183787 | 0.84 | L3MBTL1 (0.41) | L3MBTL1KMT2APOLBCYP1A2GAA | |
| SCHEMBL28215194 | 0.82 | PRKCA (0.34) | L3MBTL1KMT2APOLBCYP3A4TSHR | |
| SCHEMBL10406964 | 0.81 | L3MBTL1 (0.49) | L3MBTL1KMT2APOLBCYP1A2GAA | |
| SCHEMBL27622392 | 0.81 | L3MBTL1 (0.49) | L3MBTL1KMT2APOLBCYP1A2GAA | |
| SCHEMBL5233113 | 0.81 | KMT2A (0.49) | L3MBTL1KMT2APOLBCYP1A2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7241914-B2 | Method for producing polyesterpolyols of polyvalent alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2007-07-10 | — | — | US | claimed |
| US-20050148802-A1 | Method for producing polyetherols | BASF AKTIENGESELLSCHAFT | 2005-07-07 | — | — | US | claimed |
| US-20050010065-A1 | Method for producing (meth) acrylic acid esters of polyhydric alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-13 | — | — | US | claimed |
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2026-05-28 | — | — | US | disclosed |
| US-12539332-B2 | Anti-viral and hepatic-targeted drugs | A-BIOPHARMA (FR) | 2026-02-03 | — | — | US | disclosed |
| US-20240139325-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2024-05-02 | — | — | US | disclosed |
| EP-4045504-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | Ai-biopharma (FR) | 2022-08-24 | — | — | EP | disclosed |
| US-20170327626-A1 | METHOD FOR PRODUCING RADIATION-CURABLE URETHANE (METH)ACRYLATES | UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF NASA | 2017-11-16 | — | — | US | disclosed |
| US-7420013-B2 | Mixtures of compounds comprising at least two double bonds and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-02 | — | — | US | disclosed |
| US-7250481-B2 | Reacting polyalcohol with at least one ethylenically unsaturated carboxylic acid in the presence of at least one esterification catalyst and of at least one polymerization inhibitor, polymerizing the reaction mixture, in the presence of at least one radical initiator, postcrosslinking, drying | BASF AKTIENGESELLSCHAFT (DE) | 2007-07-31 | — | — | US | disclosed |
| US-7241914-B2 | Method for producing polyesterpolyols of polyvalent alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2007-07-10 | — | — | US | disclosed |
| US-20070129564-A1 | Method for the production of (meth)acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2007-06-07 | — | — | US | disclosed |
| US-20060235141-A1 | Mixtures of compounds comprising at least two double bonds and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2006-10-19 | — | — | US | disclosed |
| US-20060052571-A1 | Method for the production of radiation-curable urethane (meth) acrylates | BASF AKITIENGESELLSCHAFT (DE) | 2006-03-09 | — | — | US | disclosed |
| US-20050203268-A1 | Method for producing polyesterpolyols of polyvalent alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2005-09-15 | — | — | US | disclosed |
| US-20050176910-A1 | Method for the production of esters of polyalcohols | BASF AKTIENGESELLSCHAFT (DE) | 2005-08-11 | — | — | US | disclosed |
| US-20050148802-A1 | Method for producing polyetherols | BASF AKTIENGESELLSCHAFT | 2005-07-07 | — | — | US | disclosed |
| US-20050010065-A1 | Method for producing (meth) acrylic acid esters of polyhydric alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12539332-B2 | Anti-viral and hepatic-targeted drugs | HAVCR2, NR1H4, NR1H3 | L3MBTL1 588/4885KMT2A 4322/4885POLB 657/4885 |
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | HAVCR2, NR1H4, NR1H3 | L3MBTL1 1412/4885KMT2A 4167/4885POLB 906/4885 |
| US-20070129564-A1 | Method for the production of (meth)acrylic acid esters | MMAB, ACR, MCCC2 | L3MBTL1 3840/4885KMT2A 1058/4885POLB 1467/4885 |
| US-20050010065-A1 | Method for producing (meth) acrylic acid esters of polyhydric alcohols | ADH1A, ADH1C, ADH5 | L3MBTL1 3080/4885KMT2A 432/4885POLB 324/4885 |
| US-20050148802-A1 | Method for producing polyetherols | ADH1A, ADH1C, ADH5 | L3MBTL1 3028/4885KMT2A 509/4885POLB 768/4885 |
| US-20240139325-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | SLC10A1, HAVCR2, HDGF | L3MBTL1 3538/4885KMT2A 4427/4885POLB 138/4885 |
| US-20050203268-A1 | Method for producing polyesterpolyols of polyvalent alcohols | ADH1C, ADH1A, ADH5 | L3MBTL1 3142/4885KMT2A 634/4885POLB 711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.